Critical comparison of optimal flu vaccine modality | InvVax

https://wefunder.com/feed/171398

Published at: 2024-03-08 22:30:42 UTC

Author: Arthur Young

Subject: InvVax

Greetings everyone, We're happy to say that our pivotal flu vaccine mouse study with Duke University is underway! Funded by an NIH grant through the Duke CIVICs program (Collaborative Influenza Vaccine Innovation Centers), we're comparing our aden...

Founders

Community Round Private Round Investor Warmup Pricing Case Studies Verticals Legal Primer Founder Playbook

Syndicates & Funds

Syndicate Fund SPV

Learn

Charter & Impact Report Careers Knowledge Base Blog Press Help Center

Platform

API & Agents Invest Explore Vault

Wefunder means Wefunder Inc and its subsidiaries: Wefunder Advisors LLC, Capitalize Advisors LLC, and Wefunder Portal LLC. This page is hosted by Wefunder Inc.

Wefunder Portal LLC is a member of the Financial Industry Regulatory Authority (FINRA). Wefunder Portal LLC is located in Gun Barrel City, Texas.

Investing is risky. You could lose all your money. Only invest what you can afford to lose. Most investments are hard to sell, and there's no promise you'll get your money back or make a profit. Wefunder does not offer investment advice. Do your own research.

Important Disclosures Terms Privacy Cookies